Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

doi:10.1084/jem.180.1.341

This Article

	Full Text (PDF, 1774K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Fava, R. A.
	Articles by Brown, L. F.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Fava, R. A.
	Articles by Brown, L. F.


Social Bookmarking

	What's this?

ARTICLES

Vascular permeability factor/endothelial growth factor (VPF/VEGF): accumulation and expression in human synovial fluids and rheumatoid synovial tissue

RA Fava, NJ Olsen, G Spencer-Green, KT Yeo, TK Yeo, B Berse, RW Jackman, DR Senger, HF Dvorak and LF Brown
Research Service (151), Veterans Affairs Medical Center, White River Junction, Vermont 05009.

Vascular permeability factor (VPF, also known as vascular endothelial growth factor or VEGF), is a potent microvascular permeability enhancing cytokine and a selective mitogen for endothelial cells. It has been implicated in tumor angiogenesis and ascites fluid accumulation. Since development of the destructive synovial pannus in rheumatoid arthritis (RA) is associated with changes in vascular permeability (synovial fluid accumulation), synovial cell hyperplasia, and angiogenesis, we examined synovial fluids (SFs) and joint tissue for the expression and local accumulation of VPF/VEGF. VPF/VEGF was detected in all of 21 synovial fluids examined and when measured by an immunofluorimetric assay, ranged from 6.9 to 180.5 pM. These levels are biologically significant, since < 1 pM VPF/VEGF can elicit responses from its target cells, endothelial cells. Levels of VPF/VEGF were highest in rheumatoid arthritis fluids (n = 10), with a mean value (+/- SEM) of 59.1 +/- 18.0 pM, vs. 21.4 +/- 2.3 pM for 11 SFs from patients with other forms of arthritis (p = 0.042). In situ hybridization studies that were performed on joint tissues from patients with active RA revealed that synovial lining macrophages strongly expressed VPF/VEGF mRNA, and that microvascular endothelial cells of nearby blood vessels strongly expressed mRNA for the VPF/VEGF receptors, flt-1 and KDR. Immunohistochemistry performed on inflamed rheumatoid synovial tissue revealed that the VPF/VEGF peptide was localized to macrophages within inflamed synovium, as well as to microvascular endothelium, its putative target in the tissue. Together, these findings indicate that VPF/VEGF may have an important role in the pathogenesis of RA.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Facebook Add to Reddit Reddit Add to Technorati Technorati Twitter What's this?

This article has been cited by other articles:

HASEGAWA, M., NAKOSHI, Y., IINO, T., SUDO, A., SEGAWA, T., MAEDA, M., YOSHIDA, T., UCHIDA, A. (2009). Thrombin-Cleaved Osteopontin in Synovial Fluid of Subjects with Rheumatoid Arthritis. The Journal of Rheumatology 36: 240-245 [Abstract] [Full Text]
Movahedi, B., Gysemans, C., Jacobs-Tulleneers-Thevissen, D., Mathieu, C., Pipeleers, D. (2008). Pancreatic Duct Cells in Human Islet Cell Preparations Are a Source of Angiogenic Cytokines Interleukin-8 and Vascular Endothelial Growth Factor. Diabetes 57: 2128-2136 [Abstract] [Full Text]
Ahn, J. K., Koh, E.-M., Cha, H.-S., Lee, Y. S., Kim, J., Bae, E.-K., Ahn, K.-S. (2008). Role of hypoxia-inducible factor-1{alpha} in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology (Oxford) 47: 834-839 [Abstract] [Full Text]
Kowanetz, M., Ferrara, N. (2008). Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective. aacredbook 2008: 173-181 [Abstract] [Full Text]
Kamijo, S., Nakajima, A., Kamata, K., Kurosawa, H., Yagita, H., Okumura, K. (2008). Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA. Rheumatology (Oxford) 47: 442-450 [Abstract] [Full Text]
Sakuma, M., Hatsushika, K., Koyama, K., Katoh, R., Ando, T., Watanabe, Y., Wako, M., Kanzaki, M., Takano, S., Sugiyama, H., Hamada, Y., Ogawa, H., Okumura, K., Nakao, A. (2007). TGF-{beta} type I receptor kinase inhibitor down-regulates rheumatoid synoviocytes and prevents the arthritis induced by type II collagen antibody. Int Immunol 19: 117-126 [Abstract] [Full Text]
Ray, B. K., Shakya, A., Ray, A. (2007). Vascular Endothelial Growth Factor Expression in Arthritic Joint Is Regulated by SAF-1 Transcription Factor. J. Immunol. 178: 1774-1782 [Abstract] [Full Text]
Kim, W.-U., Kang, S. S., Yoo, S.-A., Hong, K.-H., Bae, D.-G., Lee, M.-S., Hong, S. W., Chae, C.-B., Cho, C.-S. (2006). Interaction of Vascular Endothelial Growth Factor 165 with Neuropilin-1 Protects Rheumatoid Synoviocytes from Apoptotic Death by Regulating Bcl-2 Expression and Bax Translocation. J. Immunol. 177: 5727-5735 [Abstract] [Full Text]
Murakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., Shibuya, M. (2006). Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes/macrophages. Blood 108: 1849-1856 [Abstract] [Full Text]
Kowanetz, M., Ferrara, N. (2006). Vascular Endothelial Growth Factor Signaling Pathways: Therapeutic Perspective. Clin. Cancer Res. 12: 5018-5022 [Abstract] [Full Text]
Taylor, P. C. (2005). Serum vascular markers and vascular imaging in assessment of rheumatoid arthritis disease activity and response to therapy. Rheumatology (Oxford) 44: 721-728 [Abstract] [Full Text]
Yoo, S.-A., Bae, D.-G., Ryoo, J.-W., Kim, H.-R., Park, G.-S., Cho, C.-S., Chae, C.-B., Kim, W.-U. (2005). Arginine-Rich Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Hexapeptide Inhibits Collagen-Induced Arthritis and VEGF-Stimulated Productions of TNF-{alpha} and IL-6 by Human Monocytes. J. Immunol. 174: 5846-5855 [Abstract] [Full Text]
Grisar, J., Aletaha, D., Steiner, C. W., Kapral, T., Steiner, S., Seidinger, D., Weigel, G., Schwarzinger, I., Wolozcszuk, W., Steiner, G., Smolen, J. S. (2005). Depletion of Endothelial Progenitor Cells in the Peripheral Blood of Patients With Rheumatoid Arthritis. Circulation 111: 204-211 [Abstract] [Full Text]
Park, Y. W., Kang, Y. M., Butterfield, J., Detmar, M., Goronzy, J. J., Weyand, C. M. (2004). Thrombospondin 2 Functions as an Endogenous Regulator of Angiogenesis and Inflammation in Rheumatoid Arthritis. Am. J. Pathol. 165: 2087-2098 [Abstract] [Full Text]
Han, S. W., Kim, G. W., Seo, J. S., Kim, S. J., Sa, K. H., Park, J. Y., Lee, J., Kim, S. Y., Goronzy, J. J., Weyand, C. M., Kang, Y. M. (2004). VEGF gene polymorphisms and susceptibility to rheumatoid arthritis. Rheumatology (Oxford) 43: 1173-1177 [Abstract] [Full Text]
Ferrara, N. (2004). Vascular Endothelial Growth Factor: Basic Science and Clinical Progress. Endocr. Rev. 25: 581-611 [Abstract] [Full Text]
Alatas, F., Alatas, O., Metintas, M., Ozarslan, A., Erginel, S., Yildirim, H. (2004). Vascular Endothelial Growth Factor Levels in Active Pulmonary Tuberculosis. Chest 125: 2156-2159 [Abstract] [Full Text]
Wu, Y., Zhang, Q., Ann, D. K., Akhondzadeh, A., Duong, H. S., Messadi, D. V., Le, A. D. (2004). Increased vascular endothelial growth factor may account for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am. J. Physiol. Cell Physiol. 286: C905-C912 [Abstract] [Full Text]
Bussolati, B., Ahmed, A., Pemberton, H., Landis, R. C., Di Carlo, F., Haskard, D. O., Mason, J. C. (2004). Bifunctional role for VEGF-induced heme oxygenase-1 in vivo: induction of angiogenesis and inhibition of leukocytic infiltration. Blood 103: 761-766 [Abstract] [Full Text]
Pufe, T., Lemke, A., Kurz, B., Petersen, W., Tillmann, B., Grodzinsky, A. J., Mentlein, R. (2004). Mechanical Overload Induces VEGF in Cartilage Discs via Hypoxia-Inducible Factor. Am. J. Pathol. 164: 185-192 [Abstract] [Full Text]
De Bandt, M., Ben Mahdi, M. H., Ollivier, V., Grossin, M., Dupuis, M., Gaudry, M., Bohlen, P., Lipson, K. E., Rice, A., Wu, Y., Gougerot-Pocidalo, M.-A., Pasquier, C. (2003). Blockade of Vascular Endothelial Growth Factor Receptor I (VEGF-RI), but not VEGF-RII, Suppresses Joint Destruction in the K/BxN Model of Rheumatoid Arthritis. J. Immunol. 171: 4853-4859 [Abstract] [Full Text]
Koch, A E (2003). Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 62: ii60-67 [Full Text]
Avraham, H. K., Lee, T.-H., Koh, Y., Kim, T.-A., Jiang, S., Sussman, M., Samarel, A. M., Avraham, S. (2003). Vascular Endothelial Growth Factor Regulates Focal Adhesion Assembly in Human Brain Microvascular Endothelial Cells through Activation of the Focal Adhesion Kinase and Related Adhesion Focal Tyrosine Kinase. J. Biol. Chem. 278: 36661-36668 [Abstract] [Full Text]
Pinhal-Enfield, G., Ramanathan, M., Hasko, G., Vogel, S. N., Salzman, A. L., Boons, G.-J., Leibovich, S. J. (2003). An Angiogenic Switch in Macrophages Involving Synergy between Toll-Like Receptors 2, 4, 7, and 9 and Adenosine A2A Receptors. Am. J. Pathol. 163: 711-721 [Abstract] [Full Text]
Terai, M., Honda, T., Yasukawa, K., Higashi, K., Hamada, H., Kohno, Y. (2003). Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease. Circulation 108: 325-330 [Abstract] [Full Text]
Felmeden, D.C, Blann, A.D, Lip, G.Y.H (2003). Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J 24: 586-603 [Full Text]
Bullard, L. E., Qi, X., Penn, J. S. (2003). Role for Extracellular Signal-Responsive Kinase-1 and -2 in Retinal Angiogenesis. IOVS 44: 1722-1731 [Abstract] [Full Text]
Marikovsky, M., Ziv, V., Nevo, N., Harris-Cerruti, C., Mahler, O. (2003). Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response. J. Immunol. 170: 2993-3001 [Abstract] [Full Text]
Gravallese, E M, Pettit, A R, Lee, R, Madore, R, Manning, C, Tsay, A, Gaspar, J, Goldring, M B, Goldring, S R, Oettgen, P (2003). Angiopoietin-1 is expressed in the synovium of patients with rheumatoid arthritis and is induced by tumour necrosis factor {alpha}. Ann Rheum Dis 62: 100-107 [Abstract] [Full Text]
Leibovich, S. J., Chen, J.-F., Pinhal-Enfield, G., Belem, P. C., Elson, G., Rosania, A., Ramanathan, M., Montesinos, C., Jacobson, M., Schwarzschild, M. A., Fink, J. S., Cronstein, B. (2002). Synergistic Up-Regulation of Vascular Endothelial Growth Factor Expression in Murine Macrophages by Adenosine A2A Receptor Agonists and Endotoxin. Am. J. Pathol. 160: 2231-2244 [Abstract] [Full Text]
Wang, D., Lehman, R. E., Donner, D. B., Matli, M. R., Warren, R. S., Welton, M. L. (2002). Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 282: G1088-G1096 [Abstract] [Full Text]
Lange-Asschenfeldt, B., Weninger, W., Velasco, P., Kyriakides, T. R., von Andrian, U. H., Bornstein, P., Detmar, M. (2002). Increased and prolonged inflammation and angiogenesis in delayed-type hypersensitivity reactions elicited in the skin of thrombospondin-2-deficient mice. Blood 99: 538-545 [Abstract] [Full Text]
Yamashita, A., Yonemitsu, Y., Okano, S., Nakagawa, K., Nakashima, Y., Irisa, T., Iwamoto, Y., Nagai, Y., Hasegawa, M., Sueishi, K. (2002). Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats. J. Immunol. 168: 450-457 [Abstract] [Full Text]
Hau, M, Kneitz, C, Tony, H-P, Keberle, M, Jahns, R, Jenett, M (2002). High resolution ultrasound detects a decrease in pannus vascularisation of small finger joints in patients with rheumatoid arthritis receiving treatment with soluble tumour necrosis factor {alpha} receptor (etanercept). Ann Rheum Dis 61: 55-58 [Abstract] [Full Text]
Hayashibara, T., Yamada, Y., Miyanishi, T., Mori, H., Joh, T., Maeda, T., Mori, N., Maita, T., Kamihira, S., Tomonaga, M. (2001). Vascular Endothelial Growth Factor and Cellular Chemotaxis: A Possible Autocrine Pathway in Adult T-Cell Leukemia Cell Invasion. Clin. Cancer Res. 7: 2719-2726 [Abstract] [Full Text]
Epstein, S. E., Kornowski, R., Fuchs, S., Dvorak, H. F. (2001). Angiogenesis Therapy : Amidst the Hype, the Neglected Potential for Serious Side Effects. Circulation 104: 115-119 [Full Text]
Hernandez, G. L., Volpert, O. V., Iniguez, M. A., Lorenzo, E., Martinez-Martinez, S., Grau, R., Fresno, M., Redondo, J. M. (2001). Selective Inhibition of Vascular Endothelial Growth Factor-Mediated Angiogenesis by Cyclosporin a: Roles of the Nuclear Factor of Activated T Cells and Cyclooxygenase 2. JEM 193: 607-620 [Abstract] [Full Text]
Melter, M., Reinders, M. E. J., Sho, M., Pal, S., Geehan, C., Denton, M. D., Mukhopadhyay, D., Briscoe, D. M. (2000). Ligation of CD40 induces the expression of vascular endothelial growth factor by endothelial cells and monocytes and promotes angiogenesis in vivo. Blood 96: 3801-3808 [Abstract] [Full Text]
Koch, A. E. (2000). The role of angiogenesis in rheumatoid arthritis: recent developments. Ann Rheum Dis 59: i65-71 [Full Text]
Feldmann, M., Miotla, J., Paleolog, E., Williams, R., Malfait, A.-M., Taylor, P., Brennan, F. M, Maini, R. N (2000). Future prospects for anti-cytokine treatment. Ann Rheum Dis 59: i119-122 [Abstract] [Full Text]
van der Flier, M., Coenjaerts, F., Kimpen, J. L. L., Hoepelman, A. M., Geelen, S. P. M. (2000). Streptococcus pneumoniae Induces Secretion of Vascular Endothelial Growth Factor by Human Neutrophils. Infect. Immun. 68: 4792-4794 [Abstract] [Full Text]
Slevin, M., Krupinski, J., Slowik, A., Kumar, P., Szczudlik, A., Gaffney, J. (2000). Serial Measurement of Vascular Endothelial Growth Factor and Transforming Growth Factor-{beta}1 in Serum of Patients With Acute Ischemic Stroke. Stroke 31: 1863-1870 [Abstract] [Full Text]
Lu, J., Kasama, T., Kobayashi, K., Yoda, Y., Shiozawa, F., Hanyuda, M., Negishi, M., Ide, H., Adachi, M. (2000). Vascular Endothelial Growth Factor Expression and Regulation of Murine Collagen-Induced Arthritis. J. Immunol. 164: 5922-5927 [Abstract] [Full Text]
Cho, C.-S., Cho, M.-L., Min, S.-Y., Kim, W.-U., Min, D.-J., Lee, S.-S., Park, S.-H., Choe, J., Kim, H.-Y. (2000). CD40 Engagement on Synovial Fibroblast Up-Regulates Production of Vascular Endothelial Growth Factor. J. Immunol. 164: 5055-5061 [Abstract] [Full Text]
Feng, D., Nagy, J. A., Brekken, R. A., Pettersson, A., Manseau, E. J., Pyne, K., Mulligan, R., Thorpe, P. E., Dvorak, H. F., Dvorak, A. M. (2000). Ultrastructural Localization of the Vascular Permeability Factor/Vascular Endothelial Growth Factor (VPF/VEGF) Receptor-2 (FLK-1, KDR) in Normal Mouse Kidney and in the Hyperpermeable Vessels Induced by VPF/VEGF-expressing Tumors and Adenoviral Vectors. J. Histochem. Cytochem. 48: 545-556 [Abstract] [Full Text]
Wood, J. M., Bold, G., Buchdunger, E., Cozens, R., Ferrari, S., Frei, J., Hofmann, F., Mestan, J., Mett, H., O’Reilly, T., Persohn, E., Rösel, J., Schnell, C., Stover, D., Theuer, A., Towbin, H., Wenger, F., Woods-Cook, K., Menrad, A., Siemeister, G., Schirner, M., Thierauch, K.-H., Schneider, M. R., Drevs, J., Martiny-Baron, G., Totzke, F., Marmé, D. (2000). PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration. Cancer Res. 60: 2178-2189 [Abstract] [Full Text]
Verheul, H.M.W., Hoekman, K., Jorna, A.S., Smit, E.F., Pinedo, H.M. (2000). Targeting Vascular Endothelial Growth Factor Blockade: Ascites and Pleural Effusion Formation. The Oncologist 5: 45-50 [Abstract] [Full Text]
Carlevaro, M., Cermelli, S, Cancedda, R, Descalzi Cancedda, F (2000). Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. J. Cell Sci. 113: 59-69 [Abstract]
SHIJUBO, N., UEDE, T., KON, S., MAEDA, M., SEGAWA, T., IMADA, A., HIRASAWA, M., ABE, S. (1999). Vascular Endothelial Growth Factor and Osteopontin in Stage I Lung Adenocarcinoma. Am. J. Respir. Crit. Care Med. 160: 1269-1273 [Abstract] [Full Text]
Dahlqvist, A., Umemoto, E. Y., Brokaw, J. J., Dupuis, M., McDonald, D. M. (1999). Tissue Macrophages Associated with Angiogenesis in Chronic Airway Inflammation in Rats. Am. J. Respir. Cell Mol. Bio. 20: 237-247 [Abstract] [Full Text]
Bellamy, W. T., Richter, L., Frutiger, Y., Grogan, T. M. (1999). Expression of Vascular Endothelial Growth Factor and Its Receptors in Hematopoietic Malignancies. Cancer Res. 59: 728-733 [Abstract] [Full Text]
Lin, Y. S., Nguyen, C., Mendoza, J.-L., Escandon, E., Fei, D., Meng, Y. G., Modi, N. B. (1999). Preclinical Pharmacokinetics, Interspecies Scaling, and Tissue Distribution of a Humanized Monoclonal Antibody against Vascular Endothelial Growth Factor. J. Pharmacol. Exp. Ther. 288: 371-378 [Abstract] [Full Text]
Kupprion, C., Motamed, K., Sage, E. H. (1998). SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells. J. Biol. Chem. 273: 29635-29640 [Abstract] [Full Text]
Xiong, M., Elson, G., Legarda, D., Leibovich, S. J. (1998). Production of Vascular Endothelial Growth Factor by Murine Macrophages : Regulation by Hypoxia, Lactate, and the Inducible Nitric Oxide Synthase Pathway. Am. J. Pathol. 153: 587-598 [Abstract] [Full Text]
Siemeister, G., Marme, D., Martiny-Baron, G. (1998). The alpha -Helical Domain Near the Amino Terminus Is Essential for Dimerization of Vascular Endothelial Growth Factor. J. Biol. Chem. 273: 11115-11120 [Abstract] [Full Text]
Siemeister, G., Schirner, M., Reusch, P., Barleon, B., Marme, D., Martiny-Baron, G. (1998). An antagonistic vascular endothelial growth factor (VEGF) variant inhibits VEGF-stimulated receptor autophosphorylation and proliferation of human endothelial cells. Proc. Natl. Acad. Sci. USA 95: 4625-4629 [Abstract] [Full Text]
Gaffney, K., Cookson, J., Blades, S., Coumbe, A., Blake, D. (1998). Quantitative assessment of the rheumatoid synovial microvascular bed by gadolinium-DTPA enhanced magnetic resonance imaging. Ann Rheum Dis 57: 152-157 [Abstract] [Full Text]
Claffey, K. P., Shih, S.-C., Mullen, A., Dziennis, S., Cusick, J. L., Abrams, K. R., Lee, S. W., Detmar, M. (1998). Identification of a Human VPF/VEGF 3' Untranslated Region Mediating Hypoxia-induced mRNA Stability. Mol. Biol. Cell 9: 469-481 [Abstract] [Full Text]
Senger, D. R., Claffey, K. P., Benes, J. E., Perruzzi, C. A., Sergiou, A. P., Detmar, M. (1997). Angiogenesis promoted by vascular endothelial growth factor: Regulation through alpha 1beta 1 and alpha 2beta 1�integrins. Proc. Natl. Acad. Sci. USA 94: 13612-13617 [Abstract] [Full Text]
Gaudry, M., Bregerie, O., Andrieu, V., El Benna, J., Pocidalo, M.-A., Hakim, J. (1997). Intracellular Pool of Vascular Endothelial Growth Factor in Human Neutrophils. Blood 90: 4153-4161 [Abstract] [Full Text]
Cheng, S.-Y., Nagane, M., Huang, H.-J. S., Cavenee, W. K. (1997). Intracerebral tumor-associated hemorrhage caused by overexpression of the vascular endothelial growth factor isoforms VEGF121 and VEGF165 but not�VEGF189. Proc. Natl. Acad. Sci. USA 94: 12081-12087 [Abstract] [Full Text]
Sato, K., Miyakawa, M., Onoda, N., Demura, H., Yamashita, T., Miura, M., Kasajima, T., Yamazaki, K., Obara, T. (1997). Increased Concentration of Vascular Endothelial Growth Factor/Vascular Permeability Factor in Cyst Fluid of Enlarging and Recurrent Thyroid Nodules. J. Clin. Endocrinol. Metab. 82: 1968-1973 [Abstract] [Full Text]
SCHLINGEMANN, R. O, VAN HINSBERGH, V. W M (1997). Role of vascular permeability factor/vascular endothelial growth factor in eye disease. Br J Ophthalmol 81: 501-512 [Full Text]
Wijelath, E., Carlsen, B, Cole, T, Chen, J, Kothari, S, Hammond, W. (1997). Oncostatin M induces basic fibroblast growth factor expression in endothelial cells and promotes endothelial cell proliferation, migration and spindle morphology. J. Cell Sci. 110: 871-879 [Abstract]
Kovacs, Z., Ikezaki, K., Samoto, K., Inamura, T., Fukui, M., Kawamata, T., Finklestein, S. P. (1996). VEGF and flt: Expression Time Kinetics in Rat Brain Infarct. Stroke 27: 1865-1873 [Abstract] [Full Text]
Keyt, B. A., Nguyen, H. V., Berleau, L. T., Duarte, C. M., Park, J., Chen, H., Ferrara, N. (1996). Identification of Vascular Endothelial Growth Factor Determinants for Binding KDR and FLT-1 Receptors. J. Biol. Chem. 271: 5638-5646 [Abstract] [Full Text]
Thomas, K. A., Thomas, K. A. (1996). Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent. J. Biol. Chem. 271: 603-606 [Full Text]
Bhattacharjee, G., Asplin, I. R., Wu, S. M., Gawdi, G., Pizzo, S. V. (2000). The Conformation-dependent Interaction of alpha 2-Macroglobulin with Vascular Endothelial Growth Factor. A NOVEL MECHANISM OF alpha 2-MACROGLOBULIN/GROWTH FACTOR BINDING. J. Biol. Chem. 275: 26806-26811 [Abstract] [Full Text]